Laura Mc Cullagh
Associate Professor
Pharmacology & Therapeutics
Trinity College Dublin
Ireland
Biography
In January 2016, Laura was appointed to the post of Associate Professor of Pharmacoeconomics & Health Technology Assessment. Laura graduated from the Sunderland School of Pharmacy (First Class Hons). She holds a PhD from the Department of Pharmacology & Therapeutics, Trinity College Dublin, for her research which focused on Health Technology Assessment within the Irish Healthcare Setting. Subsequent to this, Laura was appointed as a Health Research Board (ICE) Research Fellow working with the Cancer Pharmacoepidemiology and Pharmacoeconomics (CAPPE) Research Group. Research interests to date include pharmacoeconomic evaluation, value of information analysis, multiple criteria decision analysis, survival analysis, cost of care studies and analysis of drug utilisation and expenditure in the real world setting. Laura has been a member of the National Centre for Pharmacoeconomics (NCPE) Review Group for economic evaluations since 2008. In this capacity, Laura has been the lead author on over 20 Reports detailing the Pharmacoeconomics Evaluation of drugs submitted to the NCPE for evaluation prior to a reimbursement decision being made by the HSE. Previous roles have included Chief II Pharmacist in St James's Hospital, Dublin and Senior Medicines Information Pharmacist, Oxford Radcliffe Trust, UK.
Research Interest
Research interests to date include pharmacoeconomic evaluation, value of information analysis, multiple criteria decision analysis, survival analysis, cost of care studies and analysis of drug utilisation and expenditure in the real world setting. Laura is part of a collaborative team (including the University of Limerick, the National Cancer Registry and the NCPE)which has been awarded a HRB APA grant to examine how analysis of drug utilisation and real world outcomes databases can support pharmacoeconomic evaluations. Further, Laura is a Co-Applicant on a HRB RCQPS Award which is investigating how a GP practice-based Pharmacist Medicines Optimisation Programme might support prescribing in Irish primary care. Laura has published widely in peer reviewed journals and has presented her research at National, European and International Conferences. She has provided peer-review for a number of journals including: Value in Health, PharmacoEconomics, The European Journal of Health Economics, Thrombosis and Haemostasis, Journal of Hospital Medicine, Cost Effectiveness and Resource Allocation. She has also provided peer-review for the Innovational Research Incentive Scheme - Veni, Netherlands Organisation for Scientific Research. Laura is currently co-supervising 2 PhD students and 1 MSc student.
Publications
-
Spillane S, McCullagh L, Barry M, Usher C, Analysis of Pharmacy Claims for High Cost Oncology Products: Abiraterone and Enzalutamide Usage in Mcrpc in Ireland, Value Health, 19, (7), 2016, ppA754 - A754
-
Corcoran A, Hickey N, Barry M, Usher C, McCullagh L, Ivacaftor for cystic fibrosis; An evaluation of real world utilisation and expenditure in the Irish Healthcare Setting., Irish Medical Journal, 110, (8), 2017
-
McCullagh L, Schmitz S, Barry M, Walsh C, Examining the Feasibility and Utility of Estimating Partial Expected Value of Perfect Information (via a Nonparametric Approach) as Part of the Reimbursement Decision-Making Process in Ireland: Application to Drugs for Cancer, PharmacoEconomics, 2017